MOHAMMAD ELOMARI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MUNSTER, IN NPI 1831709153
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IN Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,227.40
- Category: General Payments
- Program years: PY2022–2024
- Record count: 29
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $331.06 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.06 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $116.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $112.98 | 1 |
| Amgen Inc. | $31.90 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.04 | 2 |
| LANTHEUS MEDICAL IMAGING, INC. | $20.44 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.18 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086858315 | Novartis Pharmaceuticals Corporation | $14.59 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086858343 | Novartis Pharmaceuticals Corporation | $14.45 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092512567 | Boston Scientific Corporation | $20.18 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105683981 | AstraZeneca Pharmaceuticals LP | $116.52 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117246017 | Amgen Inc. | $16.25 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117548463 | Amgen Inc. | $15.65 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118174497 | Boehringer Ingelheim Pharmaceuticals, Inc. | $112.98 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127580712 | LANTHEUS MEDICAL IMAGING, INC. | $20.44 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.